Biological, molecular, and clinical markers for the diagnosis and typing of lung cancer.
Gazdar
A F
AF
NCI-Navy Medical Oncology Branch, National Cancer Institute, Bethesda, Maryland.
Mulshine
J L
JL
Kramer
B S
BS
D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm / Q000032:analysis; D014408:Biomarkers, Tumor / Q000032:analysis*; D001826:Body Fluids / Q000737:chemistry; D002289:Carcinoma, Non-Small-Cell Lung / Q000175:diagnosis* / Q000235:genetics; D018288:Carcinoma, Small Cell / Q000175:diagnosis* / Q000235:genetics; D002872:Chromosome Deletion; D006729:Hormones, Ectopic / Q000097:blood; D006801:Humans; D008175:Lung Neoplasms / Q000145:classification / Q000175:diagnosis* / Q000235:genetics; D009363:Neoplasm Proteins / Q000032:analysis; D009384:Paraneoplastic Endocrine Syndromes / Q000175:diagnosis; D011519:Proto-Oncogenes
D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D006729:Hormones, Ectopic; D009363:Neoplasm Proteins